?投稿通道

?參會通道

關(guān)于工程方向?qū)W術(shù)會議的投稿須知.pdf

STP-Template-CN.doc

Professor Ahmed Hashash has completed his PhD from Manchester University, UK. He is a fellow of the California Institute of Regenerative Medicine (CIRM) and New?York?University Medical?School?(MSSM), USA. Prof. Ahmed Hashash worked as a senior biomedical research scientist at?Mount?Sinai School of Medicine of New?York?University and Children’s Hospital Los Angeles. He?was?Assistant Professor and Principal Investigator of Stem Cell & Regenerative Medicine at Keck School of Medicine and Ostrow School of Dentistry of The University of Southern California, USA. In 2016, Prof. Hashash has joined The University of Edinburgh, Edinburgh Medical School-Zhejiang International Campus, (ZJU) as?Tenure-Track?Associate Professor and Senior Principal Investigator ?of Biomedicine, Stem Cell & Regenerative Medicine. He is also adjunct Professor at the School of Basic Medical Science and School of Medicine, Zhejiang University. Prof. Hashash has several breakthrough discoveries in genes/enzymes that control stem cell behavior and regenerative medicine. He has published more than 25 papers in reputed international journals and?serving

as an editorial board member of repute. Prof. El-Hashash acts as a discussion leader at the prestigious Gordon Research Seminar/Conference in USA, and a Peer Reviewer/ International Extramural Review for The Medical Research Council (MRC) grant applications, London, UK. He is invited to speak at several international conferences in USA, Spain, Greece, Egypt and China. He is the editor or author of several books on stem cell and regenerative medicine.

史俊峰，本科畢業(yè)于湘潭大學(xué)化學(xué)系，在中山大學(xué)獲得碩士學(xué)位后，于2009年前往美國布蘭戴斯大學(xué)Bing Xu組攻讀博士學(xué)位。2015年進(jìn)入美國國立癌癥研究所（NCI，NIH）Schneider組從事博士后研究。2019年加入湖南大學(xué)生物學(xué)院，聘為教授、岳麓學(xué)者。主要研究方向是：1）多肽生物材料；2）細(xì)胞穿膜肽；3）多肽藥物的研發(fā)。目前在JACS、Angew Chem.等期刊發(fā)表論文64篇，申請美國專利1個，中國專利3個，參與撰寫著作1章。成果被美國C&EN多次報道，總引用次數(shù)過4300次。受邀在美國化學(xué)會年會（ACS）、國際材料學(xué)會年會（MRS）、中國國際多肽會議（CPS）等國際會議上做報告和特邀報告。目前主持國家自然科學(xué)基金2項，湖南自然科學(xué)基金2項。2019年入選“湖湘高層次人才聚集工程”，2020年入選“湖湘英才”和“芙蓉學(xué)者獎勵計劃”。

Cell therapy technology

Principle of medical instrument

Medical imaging instrument

Medicine, Diagnostics

Surgery

Physiology

Medical electronics

Biological pharmacy

Individualized treatment

Medicinal chemistry

Pharmaceutical analysis and drug control

Pharmaceutical technology

Pharmacology

Pharmaceutical biology (pharmacognosy)

Drug absorption and metabolism

Pharmacokinetics and pharmacodynamics

Drug delivery

Pharmaceutical care

Clinical drug evaluation

Toxicology

Medical big data and machine learning

Application of artificial intelligent for biomedical signal processing

Signal quality assessment for dynamic data monitoring

Analysis of ECG, PCG, EEG, EMG, blood pressure, pulse, respiration and

sleep signals

Telemedicine, mobile health and internet of things technologies in

medical applications

Algorithms, models, software, and tools in Bioinformatics

Biostatistics and Stochastic Models

Computational evolutionary biology

Computational Intelligence

Computational Molecular Systems

Computational Neuroscience

Data acquisition, normalization, analysis and visualization

Data management and modelling tools

Data Mining and Machine Learning

Databases and Data Management

Drug design and computer aided diagnosis

More Click

注意事項：

1、會議僅接受【全英稿件】。如需翻譯服務(wù)，可聯(lián)系會議負(fù)責(zé)人（黃老師 13922159104）。

2、論文應(yīng)具有學(xué)術(shù)或?qū)嵱脙r值，未在國內(nèi)外學(xué)術(shù)期刊或會議發(fā)表過。發(fā)表論文的作者需提交全文進(jìn)行同行評審，只做報告不發(fā)表論文的作者只需提交摘要。

3、作者可通過CrossCheck, Turnitin或其他查詢體統(tǒng)自費查重，否則由文章重復(fù)率引起的被拒搞將由作者自行承擔(dān)責(zé)任。涉嫌抄襲的論文將不被出版，且公布在會議主頁。

早鳥優(yōu)惠：（4月25日前完成繳費）：3000元/篇

3200RMB/篇

早鳥優(yōu)惠：（4月25日前完成繳費）：1000元/人

1200RMB/人